Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer. (April 2018) - Paralta Branco, F.; Silva, F.; André, S.; Catarino, A.; Madureira, R.; Moreira Pinto, J.; Godinho, J.; Simões, P.; Freitas, A.C.; Casa-Nova, M.; Nave, M.; Augusto, J.; et al.